United Therapeutics (UTHR) Asset Utilization Ratio (2010 - 2026)

United Therapeutics has disclosed Asset Utilization Ratio across 17 years of filings, most recently posting 0.45 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio rose 15.13% year-over-year to 0.45; the TTM figure through Jun 2026 stood at 0.45 (up 15.13% YoY), while the FY2025 annual figure was 0.42, up 5.44% from the prior year.
• Asset Utilization Ratio came in at 0.45 for Q2 2026 at United Therapeutics, up from 0.43 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.45 in Q2 2026 to a low of 0.32 in Q1 2023.
• Average Asset Utilization Ratio over 5 years is 0.37, with a median of 0.38 recorded in 2024.
• Year-over-year, Asset Utilization Ratio decreased 4.79% in 2023 and gained 23.76% in 2024.
• Over 5 years, Asset Utilization Ratio stood at 0.33 in 2022, then rose by 0.17% to 0.33 in 2023, then gained by 21.1% to 0.4 in 2024, then rose by 5.21% to 0.42 in 2025, then grew by 8.34% to 0.45 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.45 in Q2 2026, 0.43 in Q1 2026, and 0.42 in Q4 2025.